Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Ultraspeed Resolution Reveals that Ubiquitins Bind Sequentially

By LabMedica International staff writers
Posted on 15 Dec 2009
An innovative reaction quenching protocol with millisecond resolution has revealed that cells attach ubiquitin chains to proteins marked for destruction link by link rather than all at once. More...


The addition of a chain of four or more ubiquitin molecules to a target protein marks that protein for destruction by protein-degrading complexes in the cell. Heretofore, it was not known whether these molecules were added to the target protein sequentially or as a pre-formed chain.

In the current study, investigators at California Institute of Technology (Pasadena, USA) developed new methodology to study the action of ubiquitin ligase, the enzyme complex that attaches ubiquitin to the target protein at short time intervals that had not previously been possible. For this purpose, they adapted an instrument called a "quench-flow" machine, a machine that allows for extreme precision in the stopping, or "quenching," of a reaction. This instrument allowed them to follow changes in structure at intervals as short as 10 milliseconds in both yeast and human proteins.

"We devised methods to take snapshots of ubiquitin ligase reactions at a rate of up to 100 "pictures" every second," said senior author Dr. Raymond Deshaies, professor of biology at the California Institute of Technology. "This enables us to see things that would normally evade detection. Prior methods did not have sufficient time resolution to see what was going on. It is as if you gave an ice-cream cone to a kid and took pictures every minute. You would see the ice cream disappear from the first photo to the next, but since the pictures are too far apart in time, you would have no idea whether the child ate the ice cream one bite at a time, or swallowed the entire scoop in one gulp."

Results published in the December 3, 2009, issue of the journal Nature revealed that the three ubiquitin ligase enzymes, E1, E2, and E3 work as a team to build polyubiquitin chains on substrates by sequential transfers of single ubiquitins.

"The new method revealed the biological equivalent of small, single bites of ice cream," said Dr. Deshaies. "Using our approach we could see that our ubiquitin ligase builds ubiquitin chains one ubiquitin at a time. Gaining these kinds of insights into the ubiquitin system is important because ubiquitin ligases play a critical role in a number of human diseases, including cancer, due to their role in the regulation of the cell cycle."

Related Links:
California Institute of Technology



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.